These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 30412261)
1. Updates in prognostic markers for gliomas. Aquilanti E; Miller J; Santagata S; Cahill DP; Brastianos PK Neuro Oncol; 2018 Nov; 20(suppl_7):vii17-vii26. PubMed ID: 30412261 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients. Takahashi Y; Nakamura H; Makino K; Hide T; Muta D; Kamada H; Kuratsu J World J Surg Oncol; 2013 Oct; 11():284. PubMed ID: 24160898 [TBL] [Abstract][Full Text] [Related]
3. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593 [TBL] [Abstract][Full Text] [Related]
4. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Wiestler B; Capper D; Hovestadt V; Sill M; Jones DT; Hartmann C; Felsberg J; Platten M; Feiden W; Keyvani K; Pfister SM; Wiestler OD; Meyermann R; Reifenberger G; Pietsch T; von Deimling A; Weller M; Wick W Neuro Oncol; 2014 Dec; 16(12):1630-8. PubMed ID: 25028501 [TBL] [Abstract][Full Text] [Related]
5. Clinical Relevance of Prognostic and Predictive Molecular Markers in Gliomas. Siegal T Adv Tech Stand Neurosurg; 2016; (43):91-108. PubMed ID: 26508407 [TBL] [Abstract][Full Text] [Related]
6. Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution. Boots-Sprenger SH; Sijben A; Rijntjes J; Tops BB; Idema AJ; Rivera AL; Bleeker FE; Gijtenbeek AM; Diefes K; Heathcock L; Aldape KD; Jeuken JW; Wesseling P Mod Pathol; 2013 Jul; 26(7):922-9. PubMed ID: 23429602 [TBL] [Abstract][Full Text] [Related]
7. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas. Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441 [TBL] [Abstract][Full Text] [Related]
8. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas. Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718 [TBL] [Abstract][Full Text] [Related]
9. Clinical impact of molecular biomarkers in gliomas. Siegal T J Clin Neurosci; 2015 Mar; 22(3):437-44. PubMed ID: 25533211 [TBL] [Abstract][Full Text] [Related]
10. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Wick W; Meisner C; Hentschel B; Platten M; Schilling A; Wiestler B; Sabel MC; Koeppen S; Ketter R; Weiler M; Tabatabai G; von Deimling A; Gramatzki D; Westphal M; Schackert G; Loeffler M; Simon M; Reifenberger G; Weller M Neurology; 2013 Oct; 81(17):1515-22. PubMed ID: 24068788 [TBL] [Abstract][Full Text] [Related]
11. Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Weller M; Stupp R; Hegi ME; van den Bent M; Tonn JC; Sanson M; Wick W; Reifenberger G Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv100-8. PubMed ID: 23095825 [TBL] [Abstract][Full Text] [Related]
12. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
13. Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas. Li MY; Wang YY; Cai JQ; Zhang CB; Wang KY; Cheng W; Liu YW; Zhang W; Jiang T PLoS One; 2015; 10(6):e0130872. PubMed ID: 26115094 [TBL] [Abstract][Full Text] [Related]
14. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Wiestler B; Capper D; Sill M; Jones DT; Hovestadt V; Sturm D; Koelsche C; Bertoni A; Schweizer L; Korshunov A; Weiß EK; Schliesser MG; Radbruch A; Herold-Mende C; Roth P; Unterberg A; Hartmann C; Pietsch T; Reifenberger G; Lichter P; Radlwimmer B; Platten M; Pfister SM; von Deimling A; Weller M; Wick W Acta Neuropathol; 2014 Oct; 128(4):561-71. PubMed ID: 25008768 [TBL] [Abstract][Full Text] [Related]
15. MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas. Horbinski C; McCortney K; Stupp R Neuro Oncol; 2021 May; 23(5):858-860. PubMed ID: 33830235 [No Abstract] [Full Text] [Related]
16. Efficacy of temozolomide is correlated with 1p loss and methylation of the deoxyribonucleic acid repair gene MGMT in malignant gliomas. Ishii D; Natsume A; Wakabayashi T; Hatano H; Asano Y; Takeuchi H; Shimato S; Ito M; Fujii M; Yoshida J Neurol Med Chir (Tokyo); 2007 Aug; 47(8):341-9; discussion 350. PubMed ID: 17721049 [TBL] [Abstract][Full Text] [Related]
17. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion. Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154 [TBL] [Abstract][Full Text] [Related]
18. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Chamberlain MC Neurology; 2014 Jun; 82(23):2147-8. PubMed ID: 24912510 [No Abstract] [Full Text] [Related]
19. Progress in the application of molecular biomarkers in gliomas. Wang J; Su HK; Zhao HF; Chen ZP; To SS Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas. Mellai M; Piazzi A; Caldera V; Annovazzi L; Monzeglio O; Senetta R; Cassoni P; Schiffer D Biomed Res Int; 2013; 2013():756302. PubMed ID: 24083241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]